All
Body Positivity After a Mastectomy: An Ongoing Quest
It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me accept my new normal.
What a Cancer Thriver Wishes They’d Known at Diagnosis
A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at diagnosis.
New Trials Target Brain, Bladder, Ovarian and Other Cancers
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.
What You Can’t Do With Cancer: Talking About the Negatives
I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, joy and reasons to keep going.
FDA Approves SIR-Spheres for Liver Cancer Treatment
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.
FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
Understanding the Risk of Overtreatment in Prostate Cancer
Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
Empowering the Immune System
TIL therapy is on the rise in melanoma, with potential for other tumor types.
Growing from Embarrassment to Admiration of My Mother’s Breast Cancer
Funding for Cancer Research: Hope in a State of Fear
Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic status.
Healing Through Advocacy and Self-Discovery After AML Diagnosis
Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek connection, and support others through advocacy.
Broken Yet Unbreakable: My Previvor Journey and the Power of Symbolism
Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.
My Imaginary Fear of Cancer Recurrence
Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.
How Multidisciplinary Care Impacts Prostate Cancer Treatment
Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.
A New Frontier in Melanoma Treatment
A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.
Reflections After Nine Years as a Bladder Cancer Survivor
Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.
Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
This Wasn’t the Plan: My Mother and Her Silence
In part 4, the author reflects on her mother’s silent strength and unwavering love during her cancer journey, as she cared for her daughter while silently battling her own illness.
Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
Tipping My Hat to the Heroes of the Cancer Community
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
Living After Cancer: A Cancer Thriver Shares Her Story
Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.
Temferon Linked to Long-Term Survival in Some With Glioblastoma
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.
A Cancer Survivor Calls Beating the Disease a ‘World Championship’
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
This Wasn’t the Plan: I Lost My Hair, Not My Fire
In part 3 of “This Wasn’t the Plan,” a young woman reflects on her father’s strength during his illness and how, after her own diagnosis, their bond became her greatest source of courage.
Social and Economic Barriers May Affect Outcomes in Blood Cancers
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Survival, Symptoms and Support in Waldenström Macroglobulinemia
Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect quality of life over time.
Therapies Which Received FDA Approval in July: What Patients Should Know
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.
A Cocktail and the Freedom I Never Expected With Cancer
After years off medication, I finally enjoyed a grapefruit cocktail — symbolizing freedom from cancer’s constant shadow and hope for the future.
Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer
Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.
